Serum Metabonomics Analysis of Liver Failure Treated by Nonbioartificial Liver Support Systems

Table 8

Clinical analysis of different nonbioartificial liver treatment patterns in patients with chronic liver failure.

Non-bioartificial liver treatment method	Index	Mean; (before and after)	Standard deviation (front and back)	The value of P
Plasma exchange	ALT(U/L)	37.80, 37.53	27.83, 18.69	0.955
	AST(U/L)	97.20, 78.20	90.85, 76.31	0.019
	ALB(g/L)	28.60, 27.86	6.21, 1.96	0.394
	ALP(U/L)	89.00, 80.13	28.71, 23.39	0.053
	r-GT(U/L)	41.40, 36.40	19.73, 18.53	0.033
	TBil(umol/L)	319.73, 223.11	145.33, 79.61	0.001
	PT(s)	24.06, 17.86	5.78, 2.60	0.001
Bilirubin adsorption	ALT(U/L)	55.33, 60.22	40.57, 38.87	0.05
	AST(U/L)	162.56, 178.33	70.30, 79.48	0.123
	ALB(g/L)	29.14, 28.82	4.32, 3.76	0.859
	ALP(U/L)	106.00, 104.78	20.71, 23.65	0.398
	r-GT(U/L)	54.00, 58.67	12.51, 13.56	0.095
	TBil(umol/L)	301.80, 210.37	90.99, 33.98	0.011
	PT(s)	20.89, 21.38	5.76, 2.66	0.213
Hemofiltration	ALT(U/L)	25.56, 26.11	12.33, 6.95	0.767
	AST(U/L)	97.89, 109.44	85.78, 99.71	0.260
	ALB(g/L)	30.21, 28.61	3.22, 1.90	0.066
	ALP(U/L)	93.56, 102.56	40.73, 45.90	0.097
	r-GT(U/L)	37.78, 39.44	21.38, 21.15	0.233
	TBil(umol/L)	229.00, 220.31	106.43, 92.20	0.441
	PT(s)	33.64, 27.87	9.01, 8.88	0.011

Note: Compared with the preclinical indexes in the treatment of nonbioartificial liver in Chronic liver failure P < 0.05, Compared with the preclinical indexes in the treatment of nonbioartificial liver in Chronic liver failure P < 0.001. There was significant statistical significance.